Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 51 out of 100. Mild cognitive impairment

Topic: Risk, prevention and care in population studies

Mild cognitive impairment (MCI) is a significant and increasingly recognized problem in individuals with type 2 diabetes mellitus (T2DM). This study aims to develop a machine-learning model to predict MCI in patients with T2DMThe dataset was obtained from a prospective cohort conducted at the Sheikh Khalifa Ibn Zaid Hospital, Casablanca, Morocco, and was randomly split into three parts. Machine learning models were trained using the training dataset, and their performance was assessed on the test dataset. The unseen data was reserved for final validation. Subsequently, recursive feature elimination was applied with the top two algorithms to identify and retain the most impactful features for predicting MCI. Then, we retrained the models using the selected variables. Finally, the variables most contributing to the prediction of MCI were represented in a Shapley Additive Explanations SHAPE value plot to better understand their contribution and their ranking in MCI prediction.The dataset included 100 patients. Extra Trees classifier was the best-performing model for mild cognitive impairment (Accuracy: 0·9310/AUC: 0·9667/ Recall: 0·9333/ Precision: 0·9333/F1: 0·9333). The most contributing factors to MCI in patients with type 2 diabetes were, respectively, diabetic retinopathy, age, serum LDL cholesterol level, microalbuminuria, HbA1c, and, serum creatinine level. Our findings suggest avenues for early intervention that could prevent the progression of cognitive impairment among patients with type 2 diabetes.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Tlemçani, F. Z. R., Aitlahbib, F., Laidi, S., Idrissi, N. A., Aasfara, J., Elamari, S., et al. (2025). Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models. PLoS ONE. https://doi.org/10.1371/journal.pone.0332442

Vancouver

Tlemçani FZR, Aitlahbib F, Laidi S, Idrissi NA, Aasfara J, Elamari S, et al. Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models. PLoS ONE. 2025. doi:10.1371/journal.pone.0332442. PMID: 41004471.

BibTeX

@article{tlemcani2025-41004471,
  author  = {Tlemçani, Fatima Zahra Rhmari and Aitlahbib, Faiçal and Laidi, Soukaina and Idrissi, Najib Al and Aasfara, Jehanne and Elamari, Saloua and Chadli, Asma and Motaib, Imane},
  title   = {{Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models}},
  journal = {PLoS ONE},
  year    = {2025},
  doi     = {10.1371/journal.pone.0332442},
  pmid    = {41004471},
  url     = {https://doi.org/10.1371/journal.pone.0332442}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study developed a machine learning model that identified diabetic retinopathy as the primary predictor of mild cognitive impairment in people with type 2 diabetes. It is about prediction and suggests avenues for early intervention, but does not test whether any intervention prevents Alzheimer's disease.

Study details

How this study scored 51/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 51 of 100.51 of 100 points earned49 not earned

Published in a peer-reviewed journal, and it is a prospective cohort study, followed forward from enrollment. Scored zero for effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (PLoS ONE)
Journal's citation record 4 / 4 PLoS ONE: journal h-index 594 (OpenAlex, 2026-10-29)
Study design 7 / 12 A prospective cohort study, followed forward from enrollment
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 100 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Imane Motaib: h-index 5 (OpenAlex, whole career)
Institution's track record 0 / 3 Université Mohammed VI Polytechnique: institution h-index 178 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41004471)
Free to read 2 / 2 Free to read
Total 51 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “mini-mental”

840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →